Renaissance Technologies’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-763,754
| Closed | -$2.26M | – | 3861 |
|
|
2019
Q3 | $2.26M | Buy |
763,754
+23,300
| +3% | +$47.8K | ﹤0.01% | 2219 |
|
|
2019
Q2 | $1.41M | Buy |
740,454
+204,015
| +38% | +$417K | ﹤0.01% | 2533 |
|
|
2019
Q1 | $1.03M | Buy |
536,439
+99,798
| +23% | +$199K | ﹤0.01% | 2655 |
|
|
2018
Q4 | $655K | Buy |
436,641
+68,700
| +19% | +$137K | ﹤0.01% | 2760 |
|
|
2018
Q3 | $868K | Buy |
367,941
+205,660
| +127% | +$444K | ﹤0.01% | 2660 |
|
|
2018
Q2 | $439K | Buy |
162,281
+138,742
| +589% | +$402K | ﹤0.01% | 2870 |
|
|
2018
Q1 | $69K | Sell |
23,539
-2,220
| -9% | -$7.28K | ﹤0.01% | 3287 |
|
|
2017
Q4 | $82K | Buy |
25,759
+2,006
| +8% | +$17.5K | ﹤0.01% | 3236 |
|
|
2017
Q3 | $363K | Buy |
23,753
+2,100
| +10% | +$34K | ﹤0.01% | 2865 |
|
|
2017
Q2 | $434K | Buy |
21,653
+4,280
| +25% | +$52.8K | ﹤0.01% | 2802 |
|
|
2017
Q1 | $174K | Buy |
17,373
+4,440
| +34% | +$49.3K | ﹤0.01% | 3019 |
|
|
2016
Q4 | $122K | Buy |
12,933
+9,460
| +272% | +$102K | ﹤0.01% | 3077 |
|
|
2016
Q3 | $38K | Buy |
+3,473
| New | +$51.5K | ﹤0.01% | 3271 |
|
|
2016
Q2 | – | Sell |
-2,240
| Closed | -$84K | – | 3607 |
|
|
2016
Q1 | $84K | Buy |
+2,240
| New | +$89.4K | ﹤0.01% | 3234 |
|
Renaissance Technologies's FCSC Position: Q4 2019 in Review
Renaissance Technologies sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 763,754 shares — an estimated $2.26M sold.
Renaissance Technologies first reported a position in FCSC in Q1 2016 and held it in 14 quarters. The position peaked at $2.26M in Q3 2019. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- Renaissance Technologies reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- Renaissance Technologies sold 763,754 Fibrocell Science Inc. shares in Q4 2019, an estimated $2.26M.
- Renaissance Technologies first reported a position in Fibrocell Science Inc. in Q1 2016 and held it in 14 quarters.
- Renaissance Technologies's Fibrocell Science Inc. position peaked at $2.26M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.